ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, May 14th.
ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) last issued its quarterly earnings data on Thursday, March 28th. The company reported ($0.17) earnings per share (EPS) for the quarter.
ENDRA Life Sciences Stock Performance
NASDAQ NDRA opened at $0.30 on Wednesday. The firm’s fifty day moving average is $0.63 and its two-hundred day moving average is $1.02. ENDRA Life Sciences has a one year low of $0.22 and a one year high of $2.79. The firm has a market cap of $3.33 million, a PE ratio of -0.16 and a beta of 1.13.
ENDRA Life Sciences Company Profile
ENDRA Life Sciences Inc develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.
See Also
- Five stocks we like better than ENDRA Life Sciences
- Russell 2000 Index, How Investors Use it For Profitable Trading
- How to Read an Earnings Report | Step by Step Guide with Tips
- Upcoming IPO Stock Lockup Period, Explained
- Datadog: In the Doghouse or Pullback to the Buyzone?
- The How And Why of Investing in Oil Stocks
- Celsius Stock’s Post-Earnings Morning Dip, Better than Coffee
Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
